Denali’s medicine and a similar one from Calico Life Sciences and AbbVie were not much different than a placebo, bringing the ...

Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the ...

Prepare for an epic food journey as I explore Las Vegas's largest buffet: the famous Bacchanal Buffet inside Caesars Palace! Today, I’m diving into their brand-new Crab Brunch, packed with endless ...

The company said Monday that fosigotifator failed to outperform placebo in slowing the neurodegenerative disease, but is ...

Twelve years after launching the successful Maple Street Biscuit Co. chain, co-founder Scott Moore is set to debut a new and ...

A fierce bird attacked a calico cat lurking under its tree territory. Footage shows the oriental magpie robin swooping down ...

It may not seem like it, but the days are slowly lengthening, and there are other bright spots in a cold and windy landscape.

Google’s ( GOOGL) anti-aging company Calico released disappointing trial results of its first ever drug.

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...

Under the terms of the deal, Alchemab and Lilly will work together on up to five new antibodies, according to a Jan. 9 ...

AbbVie, Calico and Denali Therapeutics’ hopes of treating amyotrophic lateral sclerosis (ALS) by targeting eIF2B have all ...